Using bulk RNA-sequencing data, we found that lower expression of mevalonate decarboxylase ( MVD ), mevalonate kinase ( MVK ), farnesyl diphosphate synthase ( FDPS ), and farnesyl diphosphate farnesyltransferase 1 ( FDFT1 ) was independently associated with improved survival (Figure 1CD)
Abbreviations ALD Alcoholic liver disease BMDM Bone marrow-derived macrophage BMP Bone morphogenetic protein CDT Carbohydrate-deficient transferrin C/EBP CCAAT/enhancer-binding protein CP Ceruloplasmin DAMPs Damage-associated molecular patterns DcytB Duodenal cytochrome b DMT1 Divalent metal transporter-1 EGF Epidermal growth factor EPO Erythropoietin ERFE Erythroferrone FPN Ferroportin GLUT4 Glucose transporter 4 GPX4 Glutathione peroxidase 4 GSH Glutathione HCP1 Heme carrier protein-1 HIFs Hypoxia-inducible factors HJV Hemojuvelin HO1 Heme oxygenase 1 HSCs Hepatic stellate cells HGF Hepatocyte growth factor 4-HNE 4-Hydroxy-2-nonenal IL6 Interleukin 6 IL1 Interleukin 1 IL22 Interleukin 22 IRE Iron-responsive element IRPs Iron regulatory proteins IRS1 Insulin receptor substrate 1 JAK2 Janus kinase 2 KCs Kupffer cells LCN2 Lipocalin-2 LPS Lipopolysaccharide NAC N -Acetylcysteine NAFLD Nonalcoholic fatty liver disease NASH Nonalcoholic steatohepatitis NF-B Nuclear factor-B NLRP3 NOD-like receptor family pyrin domain containing 3 NRF2 Nuclear factor erythroid 2-related factor 2 PDGFR Platelet-derived growth factor receptor ROS Reactive oxygen species SIRT1 Sirtuin1 SMA Smooth muscle -actin STAT3 Signal transducers and activators of transcription 3 TS Transferrin saturation TfR Transferrin receptor TNF Tumor necrosis factor Author contributions TZ conceived the concept of the manuscript
Besides diabetes and high blood pressure, the following additional health conditions may also contribute to CKD 1 : Cardiovascular disease Systemic or kidney infections Immune system conditions (eg, lupus) Inflammation of the glomeruli (tiny filters) in the kidneys Inherited kidney disease (eg, polycystic kidney disease) Congenital defects (eg, kidney malformation, urinary tract obstruction) Medications and toxins (eg, prolonged medication, chemical, or street drug exposure) Factors such as those described above and various others can contribute to the decline in kidney function characteristic of CKD
Efficacy Overview: HbA1c reduction of approximately 1.01.8% across clinical studies
Research in obese mice demonstrated that AOD-9604 increases beta-3 adrenergic receptor RNA expression, restoring levels comparable to those in lean mice
These units are not the same
